These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15458850)

  • 21. [Influence of depressive history on biological parameters in major depression].
    Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P
    Encephale; 2002; 28(1):51-8. PubMed ID: 11963343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between psychological distress, coping styles, and HPA axis reactivity in healthy adults.
    Hori H; Ozeki Y; Teraishi T; Matsuo J; Kawamoto Y; Kinoshita Y; Suto S; Terada S; Higuchi T; Kunugi H
    J Psychiatr Res; 2010 Oct; 44(14):865-73. PubMed ID: 20334880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcome after lithium augmentation in unipolar depression: focus on HPA system activity.
    Adli M; Bschor T; Bauer M; Lucka C; Lewitzka U; Ising M; Uhr M; Mueller-Oerlinghausen B; Baethge C
    Neuropsychobiology; 2009; 60(1):23-30. PubMed ID: 19684420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.
    Lammers CH; Garcia-Borreguero D; Schmider J; Gotthardt U; Dettling M; Holsboer F; Heuser IJ
    Biol Psychiatry; 1995 Dec; 38(12):803-7. PubMed ID: 8750038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the validity of the dexamethasone/corticotropin-releasing hormone test. Comment on: Watson, S., Gallagher, P., Smith, M.S., Ferrier, I.N., Young, A.H., 2006. The dex/CRH test--is it better than the DST? Psychoneuroendocrinology 31, 889-894.
    Van Den Eede F; Claes SJ
    Psychoneuroendocrinology; 2007 Jan; 32(1):91; author reply 92-4. PubMed ID: 17156938
    [No Abstract]   [Full Text] [Related]  

  • 26. Plasma corticosterone, dexamethasone (DEX) suppression and DEX/CRH tests in a rat model of genetic vulnerability to depression.
    Steimer T; Python A; Schulz PE; Aubry JM
    Psychoneuroendocrinology; 2007 Jun; 32(5):575-9. PubMed ID: 17512120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced suppression of adrenocorticotropic hormone and cortisol responses to hypothalamic-pituitary-adrenal function and thyrotropin-releasing hormone tests after stressful life events in patients with major depressive disorder.
    Hikichi T; Akiyoshi J; Ichioka S; Tanaka Y; Tsuru J; Goto S; Matsushita H; Hanada H; Isogawa K; Nagayama H
    Neuropsychobiology; 2007; 55(1):21-7. PubMed ID: 17556849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HPA axis functioning associated with transition to psychosis: combined DEX/CRH test.
    Thompson KN; Berger G; Phillips LJ; Komesaroff P; Purcell R; McGorry PD
    J Psychiatr Res; 2007 Aug; 41(5):446-50. PubMed ID: 16403528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in hypothalamic-pituitary-adrenal axis measures after vagus nerve stimulation therapy in chronic depression.
    O'Keane V; Dinan TG; Scott L; Corcoran C
    Biol Psychiatry; 2005 Dec; 58(12):963-8. PubMed ID: 16005439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in the hypothalamic-pituitary-adrenal axis and leptin levels during antidepressant treatment.
    Himmerich H; Zimmermann P; Ising M; Kloiber S; Lucae S; Kunzel HE; Binder EB; Holsboer F; Uhr M
    Neuropsychobiology; 2007; 55(1):28-35. PubMed ID: 17556850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression.
    Pfennig A; Kunzel HE; Kern N; Ising M; Majer M; Fuchs B; Ernst G; Holsboer F; Binder EB
    Biol Psychiatry; 2005 Feb; 57(4):336-42. PubMed ID: 15705348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.
    Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Müller-Oerlinghausen B; Bauer M
    Depress Anxiety; 2003; 17(1):43-8. PubMed ID: 12577277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of gene-gender effects of adrenergic polymorphisms on hypothalamic-pituitary-adrenal axis activity in depressed patients.
    Haefner S; Baghai TC; Schule C; Eser D; Spraul M; Zill P; Rupprecht R; Bondy B
    Neuropsychobiology; 2008; 58(3-4):154-62. PubMed ID: 19088492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High neuroticism and depressive temperament are associated with dysfunctional regulation of the hypothalamic-pituitary-adrenocortical system in healthy volunteers.
    Zobel A; Barkow K; Schulze-Rauschenbach S; Von Widdern O; Metten M; Pfeiffer U; Schnell S; Wagner M; Maier W
    Acta Psychiatr Scand; 2004 May; 109(5):392-9. PubMed ID: 15049775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ
    J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between cognitive performance and cortisol reaction to the DEX/CRH test in patients recovered from depression.
    Behnken A; Bellingrath S; Symanczik JP; Rieck MJ; Zavorotnyy M; Domschke K; Arolt V; Zwanzger P
    Psychoneuroendocrinology; 2013 Mar; 38(3):447-54. PubMed ID: 22840287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationships of DEX/CRH and GHRH test results to the outcome of depression--preliminary results suggest the GHRH test may predict relapse after discharge.
    Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
    J Psychiatr Res; 2008 Apr; 42(5):356-64. PubMed ID: 17412362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
    Künzel HE; Binder EB; Nickel T; Ising M; Fuchs B; Majer M; Pfennig A; Ernst G; Kern N; Schmid DA; Uhr M; Holsboer F; Modell S
    Neuropsychopharmacology; 2003 Dec; 28(12):2169-78. PubMed ID: 12931142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome.
    Griep EN; Boersma JW; de Kloet ER
    J Rheumatol; 1993 Mar; 20(3):469-74. PubMed ID: 8386766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Munich vulnerability study on affective disorders: premorbid neuroendocrine profile of affected high-risk probands.
    Ising M; Lauer CJ; Holsboer F; Modell S
    J Psychiatr Res; 2005 Jan; 39(1):21-8. PubMed ID: 15504420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.